|1.||Patel, Chhabi Lal: 1 article (12/2008)|
|2.||Rai, A: 1 article (12/2008)|
|3.||Gupta, Praveen K: 1 article (12/2008)|
|4.||Dahiya, Shyam S: 1 article (12/2008)|
|5.||Saxena, Sonal: 1 article (12/2008)|
|6.||Sonwane, Arvind A: 1 article (12/2008)|
|7.||Saini, Mohini: 1 article (12/2008)|
|8.||Narwal, P S: 1 article (01/2007)|
|9.||Srivastava, Neelu: 1 article (01/2007)|
|10.||Choudhury, Sangeeta: 1 article (01/2007)|
10/01/2000 - "The rabies virus glycoprotein (G) gene of the highly neuroinvasive and neurotropic strains SHBRV-18, CVS-N2c, and CVS-B2c was introduced into the non-neuroinvasive and less neurotropic SN-10 strain to provide further insight into the role of G in the pathogenesis of rabies. "
01/01/2007 - "Further, canine ZP3 has also been expressed in insect cells as a fusion protein with rabies virus glycoprotein G (RV-G), an antigen that is involved in providing protection against rabies. "
12/02/2008 - "A sindbis virus replicon-based DNA vaccine encoding rabies virus glycoprotein (G) was developed by subcloning rabies G gene into a sindbis virus replicon-based vaccine vector (pAlpha). "
01/23/2006 - "We have previously determined that dogs vaccinated intradermally (i.d.) in ear pinnae with a rabies DNA vaccine expressing a rabies virus glycoprotein (G) produce high levels of neutralizing antibody that persist for at least 6 months. "
|2.||DNA (Deoxyribonucleic Acid)